Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia

BACKGROUND: Schizophrenia is associated with a lowered life expectancy due to cardiovascular disease. This is, at least in part, related to an increased vulnerability to the development of metabolic syndrome (MetS) in patients with schizophrenia. The dysregulation of apolipoproteins (Apos) may also...

Descripción completa

Detalles Bibliográficos
Autores principales: Boiko, Anastasiia S., Mednova, Irina A., Kornetova, Elena G., Semke, Arkadiy V., Bokhan, Nikolay A., Loonen, Anton J.M., Ivanova, Svetlana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611937/
https://www.ncbi.nlm.nih.gov/pubmed/31317083
http://dx.doi.org/10.1016/j.heliyon.2019.e02033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611937/
https://www.ncbi.nlm.nih.gov/pubmed/31317083
http://dx.doi.org/10.1016/j.heliyon.2019.e02033

Ejemplares similares